FCG Investment Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
12,049
+10,243
+567% +$1.2M 0.54% 50
2026
Q1
$217K Buy
+1,806
New +$209K 0.1% 98
2025
Q1
Sell
-9,950
Closed -$990K 101
2024
Q4
$990K Sell
9,950
-2,362
-19% -$244K 0.6% 51
2024
Q3
$1.4M Buy
12,312
+1,398
+13% +$166K 0.92% 37
2024
Q2
$1.35M Buy
10,914
+107
+1% +$13.8K 1.02% 25
2024
Q1
$1.43M Sell
10,807
-2,486
-19% -$306K 1.14% 25
2023
Q4
$1.45M Buy
+13,293
New +$1.38M 1.42% 21

Other funds holding MRK

FCG Investment Company's MRK Position: Q2 2026 in Review

FCG Investment Company increased its Merck (MRK) stake by 567% in Q2 2026, buying an estimated $1.2M and bringing the position to 12,049 shares worth $1.55M. The position accounts for 0.54% of the portfolio, ranked #50.

FCG Investment Company first reported a position in MRK in Q4 2023 and has held it in 7 quarters since. 1,552 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • FCG Investment Company held 12,049 shares of Merck worth $1.55M as of Q2 2026.
  • FCG Investment Company bought 10,243 Merck shares in Q2 2026, an estimated $1.2M.
  • Merck made up 0.54% of FCG Investment Company's portfolio in Q2 2026, its #50 holding.
  • FCG Investment Company first reported a position in Merck in Q4 2023 and has held it in 7 quarters since.
  • 1,552 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on FCG Investment Company's 13F filing for Q2 2026, filed 13 Jul 2026.